Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine, covering 2023-07-21 to 2023-07-21. Get the full timeline:
Most recent: Clinical Trial Update: Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older [Phase 1, Phase 2]